These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Some similarities and differences between verapamil and the dihydropyridines. Antonios TF; MacGregor GA J Hypertens Suppl; 1998 Jan; 16(1):S31-4. PubMed ID: 9534094 [TBL] [Abstract][Full Text] [Related]
8. Calcium channel blockers: rationale for their clinical use. Conti CR J Fla Med Assoc; 1981 Nov; 68(11):883-6. PubMed ID: 6120992 [No Abstract] [Full Text] [Related]
9. Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients. Fioretto P; Frigato F; Velussi M; Riva F; Muollo B; Carraro A; Brocco E; Cipollina MR; Abaterusso C; Trevisan M Am J Hypertens; 1992 Nov; 5(11):837-46. PubMed ID: 1457087 [TBL] [Abstract][Full Text] [Related]
10. Verapamil, a phenylalkylamine Ca2+ channel blocker, inhibits ATP-sensitive K+ channels in insulin-secreting cells from rats. Lebrun P; Antoine MH; Ouedraogo R; Pirotte B; Herchuelz A; Cosgrove KE; Kane C; Dunne MJ Diabetologia; 1997 Dec; 40(12):1403-10. PubMed ID: 9447947 [TBL] [Abstract][Full Text] [Related]
11. Periodic paralysis and ventricular tachycardia: possible role of calcium channel blockers. Ebeid MR; Baquero JL; Gelband H Pediatr Cardiol; 1996; 17(1):31-4. PubMed ID: 8778698 [TBL] [Abstract][Full Text] [Related]
12. Changes in myocardial blood supply during experimental hypertension treated with verapamil in rabbits. Frolov VA; Drozdova GA; Rieger P; Blagonravov M Bull Exp Biol Med; 2005 Mar; 139(3):277-8. PubMed ID: 16027829 [TBL] [Abstract][Full Text] [Related]
13. Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure. Oliveto A; Mancino M; Sanders N; Cargile C; Benjamin Guise J; Bickel W; Brooks Gentry W Eur J Pharmacol; 2013 Sep; 715(1-3):424-35. PubMed ID: 23524089 [TBL] [Abstract][Full Text] [Related]
14. Verapamil therapy for stable and unstable angina pectoris: calcium channel antagonists in perspective. Packer M; Frishman WH Am J Cardiol; 1982 Oct; 50(4):881-5. PubMed ID: 6127030 [No Abstract] [Full Text] [Related]
15. [Calcium antagonists in acute myocardial infarction]. Lotto A; Massari FM; Bertoni T; Ambrosini F; Finzi A; Foresti A; Valentini R; Matta F G Ital Cardiol; 1988 Nov; 18(11):974-81. PubMed ID: 3073992 [No Abstract] [Full Text] [Related]
16. Effects of calcium channel blockers and insulin on the platelet function in patients with diabetes mellitus. Lee YS; Hahm K; Lee SY Yonsei Med J; 1986; 27(2):132-7. PubMed ID: 3529654 [No Abstract] [Full Text] [Related]
17. Electrophysiology and antiarrhythmic effects of calcium antagonists. Russell DC Scott Med J; 1981 Apr; 26(2):161-4. PubMed ID: 6270786 [No Abstract] [Full Text] [Related]
18. Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris. Leon MB; Rosing DR; Bonow RO; Epstein SE Am J Cardiol; 1985 Jan; 55(3):69B-80B. PubMed ID: 2857518 [TBL] [Abstract][Full Text] [Related]
19. Calcium channel blockers for heart rate control in atrial fibrillation complicated by congestive heart failure. Heywood JT Can J Cardiol; 1995 Oct; 11(9):823-6. PubMed ID: 7585281 [TBL] [Abstract][Full Text] [Related]
20. Glibenclamide activates translation in rat pancreatic beta cells through calcium-dependent mTOR, PKA and MEK signalling pathways. Wang Q; Heimberg H; Pipeleers D; Ling Z Diabetologia; 2008 Jul; 51(7):1202-12. PubMed ID: 18493739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]